Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Related Citations for PubMed (Select 14630800)

1.

Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.

Levitus M, Rooimans MA, Steltenpool J, Cool NF, Oostra AB, Mathew CG, Hoatlin ME, Waisfisz Q, Arwert F, de Winter JP, Joenje H.

Blood. 2004 Apr 1;103(7):2498-503. Epub 2003 Nov 20.

2.

Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.

Siddique MA, Nakanishi K, Taniguchi T, Grompe M, D'Andrea AD.

Exp Hematol. 2001 Dec;29(12):1448-55.

PMID:
11750104
3.

Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype.

Joenje H, Lo ten Foe JR, Oostra AB, van Berkel CG, Rooimans MA, Schroeder-Kurth T, Wegner RD, Gille JJ, Buchwald M, Arwert F.

Blood. 1995 Sep 15;86(6):2156-60.

4.

Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.

Yamashita T, Nakahata T.

Int J Hematol. 2001 Jul;74(1):33-41. Review.

PMID:
11530803
5.

Evidence for at least eight Fanconi anemia genes.

Joenje H, Oostra AB, Wijker M, di Summa FM, van Berkel CG, Rooimans MA, Ebell W, van Weel M, Pronk JC, Buchwald M, Arwert F.

Am J Hum Genet. 1997 Oct;61(4):940-4.

6.

Genetic subtyping of Fanconi anemia by comprehensive mutation screening.

Ameziane N, Errami A, Léveillé F, Fontaine C, de Vries Y, van Spaendonk RM, de Winter JP, Pals G, Joenje H.

Hum Mutat. 2008 Jan;29(1):159-66.

PMID:
17924555
7.

Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.

Joenje H, Levitus M, Waisfisz Q, D'Andrea A, Garcia-Higuera I, Pearson T, van Berkel CG, Rooimans MA, Morgan N, Mathew CG, Arwert F.

Am J Hum Genet. 2000 Sep;67(3):759-62. Epub 2000 Aug 8.

8.

The Fanconi anemia pathway of genomic maintenance.

Levitus M, Joenje H, de Winter JP.

Cell Oncol. 2006;28(1-2):3-29. Review.

PMID:
16675878
9.

Fanconi anemia and DNA repair.

Grompe M, D'Andrea A.

Hum Mol Genet. 2001 Oct 1;10(20):2253-9. Review.

10.

A novel diagnostic screen for defects in the Fanconi anemia pathway.

Shimamura A, Montes de Oca R, Svenson JL, Haining N, Moreau LA, Nathan DG, D'Andrea AD.

Blood. 2002 Dec 15;100(13):4649-54. Epub 2002 Aug 29.

11.

FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.

Gordon SM, Alon N, Buchwald M.

J Biol Chem. 2005 Oct 28;280(43):36118-25. Epub 2005 Aug 26.

12.

Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.

Kalb R, Neveling K, Hoehn H, Schneider H, Linka Y, Batish SD, Hunt C, Berwick M, Callen E, Surralles J, Casado JA, Bueren J, Dasi A, Soulier J, Gluckman E, Zwaan CM, van Spaendonk R, Pals G, de Winter JP, Joenje H, Grompe M, Auerbach AD, Hanenberg H, Schindler D.

Am J Hum Genet. 2007 May;80(5):895-910. Epub 2007 Apr 6. Erratum in: Am J Hum Genet. 2007 Jul;81(1):196.

13.

Complementation group assignments in Fanconi anemia fibroblast cell lines from North America.

Jakobs PM, Fiddler-Odell E, Reifsteck C, Olson S, Moses RE, Grompe M.

Somat Cell Mol Genet. 1997 Jan;23(1):1-7.

PMID:
9217996
14.

Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.

Godthelp BC, Wiegant WW, Waisfisz Q, Medhurst AL, Arwert F, Joenje H, Zdzienicka MZ.

Mutat Res. 2006 Feb 22;594(1-2):39-48. Epub 2005 Sep 8.

PMID:
16154163
15.

The molecular biology of Fanconi anemia.

Tamary H, Bar-Yam R, Zemach M, Dgany O, Shalmon L, Yaniv I.

Isr Med Assoc J. 2002 Oct;4(10):819-23.

16.

Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.

Gallmeier E, Hucl T, Calhoun ES, Cunningham SC, Bunz F, Brody JR, Kern SE.

Cancer Biol Ther. 2007 May;6(5):654-60. Epub 2007 Feb 7.

17.

Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.

Houghtaling S, Granville L, Akkari Y, Torimaru Y, Olson S, Finegold M, Grompe M.

Cancer Res. 2005 Jan 1;65(1):85-91.

18.

Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.

Bouchlaka C, Abdelhak S, Amouri A, Ben Abid H, Hadiji S, Frikha M, Ben Othman T, Amri F, Ayadi H, Hachicha M, Rebaï A, Saad A, Dellagi K; Tunisian Fanconi Anemia Study Group.

J Hum Genet. 2003;48(7):352-61. Epub 2003 Jun 24.

PMID:
12827451
19.

The WD40 repeats of FANCL are required for Fanconi anemia core complex assembly.

Gurtan AM, Stuckert P, D'Andrea AD.

J Biol Chem. 2006 Apr 21;281(16):10896-905. Epub 2006 Feb 10.

20.

Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway.

Soulier J, Leblanc T, Larghero J, Dastot H, Shimamura A, Guardiola P, Esperou H, Ferry C, Jubert C, Feugeas JP, Henri A, Toubert A, Socié G, Baruchel A, Sigaux F, D'Andrea AD, Gluckman E.

Blood. 2005 Feb 1;105(3):1329-36. Epub 2004 Sep 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk